Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

NCT02057003 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic
Human Immunodeficiency Virus

Interventions

DRUG: DAA against HCV

Sponsor

Valme University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]